Talphera (TLPH) Interest Coverage Ratio Growth (1y) (2011 - 2025)
Talphera (TLPH) Interest Coverage Ratio Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -14.04% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -63.16% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -58.34% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 97.17% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -87.09% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -14.91% |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.59% |
| Sep 30, 2025 | 98.38% |
| Dec 31, 2024 | -111.89% |
| Sep 30, 2024 | -2,732.43% |
| Jun 30, 2024 | -2,051.68% |
| Dec 31, 2023 | 502.35% |
| Sep 30, 2023 | -558.43% |
| Jun 30, 2023 | -314.64% |
| Mar 31, 2023 | 92.15% |
| Dec 31, 2022 | -91.49% |
| Sep 30, 2022 | 68.68% |
| Jun 30, 2022 | 41.32% |
| Mar 31, 2022 | -65.30% |
| Dec 31, 2021 | -41.50% |
| Sep 30, 2021 | -46.31% |
| Jun 30, 2021 | -114.81% |
| Mar 31, 2021 | 26.61% |
| Dec 31, 2020 | 99.38% |
| Sep 30, 2020 | 32.90% |
| Jun 30, 2020 | 15.21% |